source
stringlengths 2
222
| date
stringlengths 19
19
| url
stringlengths 22
853
⌀ | text
stringlengths 0
10k
⌀ | title
stringlengths 0
701
| context_id
stringlengths 1
9
| document_id
stringclasses 2
values | document_type
stringclasses 2
values |
|---|---|---|---|---|---|---|---|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-07 11:00:00
| null |
LOS ANGELES, APRIL 7, 2021 /PRNEWSWIRE/ -- THE LAW OFFICES OF FRANK R. CRUZ ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED ON BEHALF OF PERSONS AND ENTITIES THAT PURCHASED OR OTHERWISE ACQUIRED XL FLEET CORP. ("XL FLEET" OR THE "COMPANY") (NYSE: XL) SECURITIES BETWEEN OCTOBER 2, 2020 AND MARCH 2, 2021 , INCLUSIVE (THE "CLASS PERIOD").
|
THE LAW OFFICES OF FRANK R. CRUZ ANNOUNCES THE FILING OF A SECURITIES CLASS ACTION ON BEHALF OF XL FLEET CORP. (XL) INVESTORS
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-07 07:00:00
| null |
BOSTON--(BUSINESS WIRE)--XL FLEET CORP. (NYSE: XL) (“XL FLEET” OR THE “COMPANY”), A LEADER IN FLEET ELECTRIFICATION SOLUTIONS, AND APEX CLEAN ENERGY (“APEX”), A LEADING CLEAN ENERGY COMPANY THAT DEVELOPS, CONSTRUCTS, AND OPERATES UTILITY-SCALE WIND AND SOLAR POWER FACILITIES THROUGHOUT NORTH AMERICA, TODAY ANNOUNCED THAT XL FLEET IS ELECTRIFYING APEX'S VEHICLE FLEET AS PART OF A COMPREHENSIVE EFFORT TO REDUCE ITS CARBON EMISSIONS. APEX'S FIRST INVESTMENT IN VEHICLE ELECTRIFICATION, THE ORDER WI
|
XL FLEET ELECTRIFYING APEX CLEAN ENERGY PICKUP FLEET
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-06 16:32:00
| null |
LOS ANGELES, CALIFORNIA--(NEWSFILE CORP. - APRIL 6, 2021) - THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST XL FLEET CORP. ("XL FLEET" OR "THE COMPANY") (NYSE: XL) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION.INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN OCTOBER 2, 2020 AND MARCH 2, 2021,...
|
INVESTOR ACTION ALERT: THE SCHALL LAW FIRM REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST XL FLEET CORP. AND ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100,000 TO CONTACT THE FIRM
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-06 14:23:00
| null |
SAN FRANCISCO, CALIFORNIA--(NEWSFILE CORP. - APRIL 6, 2021) - HAGENS BERMAN URGES XL FLEET CORP. (NYSE: XL) INVESTORS WITH SIGNIFICANT LOSSES TO SUBMIT YOUR LOSSES NOW. A SECURITIES FRAUD CLASS ACTION HAS BEEN FILED AND CERTAIN INVESTORS MAY HAVE VALUABLE CLAIMS.CLASS PERIOD: OCT. 2,2020 - MAR. 02, 2021LEAD PLAINTIFF DEADLINE: MAY 7, 2021VISIT: WWW.HBSSLAW.COM/INVESTOR-FRAUD/XLCONTACT AN ATTORNEY NOW: XL@HBSSLAW.COM844-916-0895XL FLEET CORP. (NYSE: XL) SECURITIES FRAUD CLASS ACTION:THE COMPLAINT ALLEGES THAT: (1) XL'S SALES PIPELI
|
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, ALERTS XL FLEET (XL) INVESTORS TO SECURITIES CLASS ACTION AND UPCOMING DEADLINE, ENCOURAGES INVESTORS WITH LOSSES TO CONTACT ITS ATTORNEYS
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-06 12:29:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - APRIL 6, 2021) - THE LAW OFFICES OF VINCENT WONG ANNOUNCE THAT A CLASS ACTION LAWSUIT HAS COMMENCED ON BEHALF OF INVESTORS WHO PURCHASED XL FLEET CORP. ("XL FLEET") (NYSE: XL) BETWEEN OCTOBER 2, 2020 AND MARCH 2, 2021.IF YOU SUFFERED A LOSS, CONTACT US AT THE LINK BELOW. THERE IS NO COST OR OBLIGATION TO YOU.HTTP://WWW.WONGESQ.COM/PSLRA-1/XL-FLEET-CORP-LOSS-SUBMISSION-FORM?PRID=14417&WIRE=5
|
XL LAWSUIT: THE LAW OFFICES OF VINCENT WONG NOTIFY INVESTORS OF A CLASS ACTION LAWSUIT INVOLVING XL FLEET CORP.
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-06 09:57:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - APRIL 6, 2021) - THE KLEIN LAW FIRM ANNOUNCES THAT A CLASS ACTION COMPLAINT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS OF XL FLEET CORP. (NYSE: XL) ALLEGING THAT THE COMPANY VIOLATED FEDERAL SECURITIES LAWS.CLASS PERIOD: OCTOBER 2, 2020 AND MARCH 2, 2021LEAD PLAINTIFF DEADLINE: MAY 7, 2021LEARN MORE ABOUT YOUR RECOVERABLE LOSSES IN XL:
|
XL ALERT: THE KLEIN LAW FIRM ANNOUNCES A LEAD PLAINTIFF DEADLINE OF MAY 7, 2021 IN THE CLASS ACTION FILED ON BEHALF OF XL FLEET CORP. LIMITED SHAREHOLDERS
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-06 06:46:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - APRIL 6, 2021) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF XL FLEET CORP. ("XL FLEET") (NYSE: XL) BETWEEN OCTOBER 2, 2020 AND MARCH 2, 2021. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK. TO...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF XL FLEET CORP. OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF MAY 7, 2021 - XL
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-06 05:10:00
| null |
NEW YORK, APRIL 6, 2021 /PRNEWSWIRE/ -- POMERANTZ LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST XL FLEET CORP. ("XL FLEET" OR THE "COMPANY") (NYSE: XL) AND CERTAIN OF ITS OFFICERS. THE CLASS ACTION, FILED IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, AND DOCKETED UNDER 21-CV-02171, IS ON BEHALF OF A CLASS CONSISTING OF ALL PERSONS AND ENTITIES OTHER THAN DEFENDANTS THAT PURCHASED OR OTHERWISE ACQUIRED XL FLEET SECURITIES BETWEEN OCTOBER 2, 2020 AND MARCH 2, 2021, INCLUSIVE (THE "CLASS PERIOD").
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM REMINDS SHAREHOLDERS WITH LOSSES ON THEIR INVESTMENT IN XL FLEET CORP. OF CLASS ACTION LAWSUIT AND UPCOMING DEADLINE - XL
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-04 21:08:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - APRIL 4, 2021) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF XL FLEET CORP. ("XL FLEET") (NYSE: XL) BETWEEN OCTOBER 2, 2020 AND MARCH 2, 2021. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK. TO GET...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF XL FLEET CORP. OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF MAY 7, 2021 - XL
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-04 03:47:00
| null |
NEW YORK, APRIL 4, 2021 /PRNEWSWIRE/ -- POMERANTZ LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST XL FLEET CORP. ("XL FLEET" OR THE "COMPANY") (NYSE: XL) AND CERTAIN OF ITS OFFICERS. THE CLASS ACTION, FILED IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, AND DOCKETED UNDER 21-CV-02171, IS ON BEHALF OF A CLASS CONSISTING OF ALL PERSONS AND ENTITIES OTHER THAN DEFENDANTS THAT PURCHASED OR OTHERWISE ACQUIRED XL FLEET SECURITIES BETWEEN OCTOBER 2, 2020 AND MARCH 2, 2021, INCLUSIVE (THE "CLASS PERIOD").
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM REMINDS SHAREHOLDERS WITH LOSSES ON THEIR INVESTMENT IN XL FLEET CORP. OF CLASS ACTION LAWSUIT AND UPCOMING DEADLINE - XL
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-04 00:42:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - APRIL 4, 2021) - POMERANTZ LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST XL FLEET CORP. ("XL FLEET" OR THE "COMPANY") (NYSE: XL) AND CERTAIN OF ITS OFFICERS. THE CLASS ACTION, FILED IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, AND DOCKETED UNDER 21-CV-02171, IS ON BEHALF OF A CLASS CONSISTING OF ALL PERSONS AND ENTITIES OTHER THAN DEFENDANTS...
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM REMINDS SHAREHOLDERS WITH LOSSES ON THEIR INVESTMENT IN XL FLEET CORP. OF CLASS ACTION LAWSUIT AND UPCOMING DEADLINE - XL
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-03 11:00:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - APRIL 3, 2021) - WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF XL FLEET CORP. (NYSE: XL) BETWEEN OCTOBER 2, 2020 AND MARCH 2, 2021, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT MAY 7, 2021 LEAD PLAINTIFF DEADLINE.SO WHAT: IF YOU PURCHASED XL FLEET SECURITIES DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF...
|
XL BREAKING ALERT: ROSEN, A TOP RANKED LAW FIRM, ENCOURAGES XL FLEET CORP. INVESTORS WITH LOSSES TO SECURE COUNSEL BEFORE IMPORTANT DEADLINE IN SECURITIES CLASS ACTION - XL
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-02 11:44:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - APRIL 2, 2021) - THE KLEIN LAW FIRM ANNOUNCES THAT A CLASS ACTION COMPLAINT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS OF XL FLEET CORP. (NYSE: XL) ALLEGING THAT THE COMPANY VIOLATED FEDERAL SECURITIES LAWS.CLASS PERIOD: OCTOBER 2, 2020 AND MARCH 2, 2021LEAD PLAINTIFF DEADLINE: MAY 7, 2021LEARN MORE ABOUT YOUR RECOVERABLE LOSSES IN XL:
|
XL ALERT: THE KLEIN LAW FIRM ANNOUNCES A LEAD PLAINTIFF DEADLINE OF MAY 7, 2021 IN THE CLASS ACTION FILED ON BEHALF OF XL FLEET CORP. LIMITED SHAREHOLDERS
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-01 14:49:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - APRIL 1, 2021) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF XL FLEET CORP. ("XL FLEET") (NYSE: XL) BETWEEN OCTOBER 2, 2020 AND MARCH 2, 2021. YOU ARE HEREBY NOTIFIED THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN COMMENCED IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK. TO GET...
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF XL FLEET CORP. OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF MAY 7, 2021 - XL
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-31 19:30:00
| null |
SAN FRANCISCO, CALIFORNIA--(NEWSFILE CORP. - MARCH 31, 2021) - HAGENS BERMAN URGES XL FLEET CORP. (NYSE: XL) INVESTORS WITH SIGNIFICANT LOSSES TO SUBMIT YOUR LOSSES NOW. A SECURITIES FRAUD CLASS ACTION HAS BEEN FILED AND CERTAIN INVESTORS MAY HAVE VALUABLE CLAIMS.CLASS PERIOD: OCT. 2,2020 - MAR. 02, 2021LEAD PLAINTIFF DEADLINE: MAY 7, 2021VISIT: WWW.HBSSLAW.COM./INVESTOR-FRAUD/XLCONTACT AN ATTORNEY NOW: XL@HBSSLAW.COM844-916-0895XL FLEET CORP. (NYSE: XL) SECURITIES FRAUD CLASS ACTION:THE COMPLAINT ALLEGES THAT: (1) XL'S SALES PIPELINES
|
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, ENCOURAGES XL FLEET (XL) INVESTORS WITH LOSSES TO CONTACT ITS ATTORNEYS NOW - IN THE WAKE OF SHORT SELLER REPORT COMPANY FORECASTS 90% REVENUE DROP IN Q1 2021
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-31 17:23:00
| null |
NEW YORK--(BUSINESS WIRE)---- $XL--THE LAW FIRM OF KIRBY MCINERNEY LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED IN THE U.S. DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK ON BEHALF OF THOSE WHO ACQUIRED XL FLEET CORP. (“XL” OR THE “COMPANY”) (NYSE: XL) SECURITIES FROM OCTOBER 2, 2020 THROUGH MARCH 2, 2021, INCLUSIVE (THE “CLASS PERIOD”). INVESTORS HAVE UNTIL MAY 7, 2021 TO APPLY TO THE COURT TO BE APPOINTED AS LEAD PLAINTIFF IN THE LAWSUIT. ON MARCH 3, 2021, MUDDY WATERS RESEARCH PUBL
|
INVESTOR ALERT: KIRBY MCINERNEY LLP ANNOUNCES THE FILING OF A SECURITIES CLASS ACTION LAWSUIT AGAINST XL FLEET CORP.
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-31 17:20:00
| null |
NEW YORK--(BUSINESS WIRE)--WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF XL FLEET CORP. (NYSE: XL) BETWEEN OCTOBER 2, 2020 AND MARCH 2, 2021, INCLUSIVE (THE “CLASS PERIOD”), OF THE IMPORTANT MAY 7, 2021 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED XL FLEET SECURITIES DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT. WHAT TO DO NEXT: TO JOIN
|
ROSEN, A LEADING AND LONGSTANDING LAW FIRM, ENCOURAGES XL FLEET CORP. INVESTORS WITH LOSSES IN EXCESS OF $100K TO SECURE COUNSEL BEFORE IMPORTANT DEADLINE IN SECURITIES CLASS ACTION – XL
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-31 16:15:00
| null |
BOSTON--(BUSINESS WIRE)--XL FLEET CORP. (NYSE: XL) (“XL FLEET” OR THE “COMPANY”), A LEADING PROVIDER OF FLEET ELECTRIFICATION SOLUTIONS FOR COMMERCIAL VEHICLES IN NORTH AMERICA, TODAY ANNOUNCED FOURTH QUARTER AND FULL-YEAR 2020 FINANCIAL RESULTS. FULL-YEAR AND RECENT HIGHLIGHTS GENERATED REVENUE FOR FULL-YEAR 2020 OF $20.3 MILLION, AN INCREASE OF 182% VS. $7.2 MILLION IN THE PRIOR YEAR GENERATED REVENUE FOR FOURTH QUARTER OF 2020 OF $10.9 MILLION, COMPARED TO $0.3 MILLION IN THE PRIOR YEAR QUAR
|
XL FLEET ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2020 FINANCIAL RESULTS
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-31 12:00:00
| null |
LOS ANGELES, MARCH 31, 2021 /PRNEWSWIRE/ -- GLANCY PRONGAY & MURRAY LLP ("GPM") REMINDS INVESTORS OF THE UPCOMING MAY 7, 2021 DEADLINE TO FILE A LEAD PLAINTIFF MOTION IN THE CLASS ACTION FILED ON BEHALF OF INVESTORS WHO PURCHASED OR OTHERWISE ACQUIRED XL FLEET CORP. ("XL FLEET" OR THE "COMPANY") (NYSE: XL) SECURITIES BETWEEN OCTOBER 2, 2020 AND MARCH 2, 2021 , INCLUSIVE (THE "CLASS PERIOD"). IF YOU SUFFERED A LOSS ON YOUR XL FLEET INVESTMENTS OR WOULD LIKE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS, YOU CAN SUBMIT YOUR CONTACT INFORMATION AT HTTPS://WWW.GLANCYLAW.COM/CASES/XL-FLEET-CORP/.
|
GLANCY PRONGAY & MURRAY LLP REMINDS INVESTORS OF LOOMING DEADLINE IN THE CLASS ACTION LAWSUIT AGAINST XL FLEET CORP. (XL)
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-31 02:51:00
| null |
NEW YORK, MARCH 31, 2021 /PRNEWSWIRE/ -- POMERANTZ LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST XL FLEET CORP. ("XL FLEET" OR THE "COMPANY") (NYSE: XL) AND CERTAIN OF ITS OFFICERS. THE CLASS ACTION, FILED IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, AND DOCKETED UNDER 21-CV-02171, IS ON BEHALF OF A CLASS CONSISTING OF ALL PERSONS AND ENTITIES OTHER THAN DEFENDANTS THAT PURCHASED OR OTHERWISE ACQUIRED XL FLEET SECURITIES BETWEEN OCTOBER 2, 2020 AND MARCH 2, 2021, INCLUSIVE (THE "CLASS PERIOD").
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM REMINDS SHAREHOLDERS WITH LOSSES ON THEIR INVESTMENT IN XL FLEET CORP. OF CLASS ACTION LAWSUIT AND UPCOMING DEADLINE - XL
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-30 10:09:00
| null |
LOS ANGELES, CALIFORNIA--(NEWSFILE CORP. - MARCH 30, 2021) - THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST XL FLEET CORP. ("XL FLEET" OR "THE COMPANY") (NYSE: XL) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION.INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN OCTOBER 2, 2020 AND MARCH 2, 2021,...
|
SHAREHOLDER ACTION NOTICE: THE SCHALL LAW FIRM REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST XL FLEET CORP. AND ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100,000 TO CONTACT THE FIRM
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-29 23:11:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - MARCH 29, 2021) - POMERANTZ LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST XL FLEET CORP. ("XL FLEET" OR THE "COMPANY") (NYSE: XL) AND CERTAIN OF ITS OFFICERS. THE CLASS ACTION, FILED IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, AND DOCKETED UNDER 21-CV-02171, IS ON BEHALF OF A CLASS CONSISTING OF ALL PERSONS AND ENTITIES OTHER THAN DEFENDANTS...
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM REMINDS SHAREHOLDERS WITH LOSSES ON THEIR INVESTMENT IN XL FLEET CORP. OF CLASS ACTION LAWSUIT AND UPCOMING DEADLINE - XL
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-29 10:07:00
| null |
LOS ANGELES, CALIFORNIA--(NEWSFILE CORP. - MARCH 29, 2021) - THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST XL FLEET CORP. ("XL FLEET" OR "THE COMPANY") (NYSE: XL) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION.INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN OCTOBER 2, 2020 AND MARCH 2, 2021,...
|
SHAREHOLDER ACTION REMINDER: THE SCHALL LAW FIRM REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST XL FLEET CORP. AND ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100,000 TO CONTACT THE FIRM
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-27 13:45:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - MARCH 27, 2021) - WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF XL FLEET CORP. (NYSE: XL) BETWEEN OCTOBER 2, 2020 AND MARCH 2, 2021, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT MAY 7, 2021 LEAD PLAINTIFF DEADLINE.SO WHAT: IF YOU PURCHASED XL FLEET SECURITIES DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT...
|
ROSEN, GLOBAL INVESTOR COUNSEL, ENCOURAGES XL FLEET CORP. INVESTORS TO SECURE COUNSEL BEFORE IMPORTANT DEADLINE IN SECURITIES CLASS ACTION - XL
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-26 13:29:00
| null |
LOS ANGELES, MARCH 26, 2021 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST XL FLEET CORP. ("XL FLEET" OR "THE COMPANY") (NYSE: XL) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN OCTOBER 2, 2020 AND MARCH 2, 2021, INCLUSIVE (THE ''CLASS PERIOD''), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE MAY 7, 2021.
|
SHAREHOLDER ACTION ALERT: THE SCHALL LAW FIRM REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST XL FLEET CORP. AND ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100,000 TO CONTACT THE FIRM
|
XL
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-02-14 08:35:00
| null |
— TRANSACTION CREATES HIGH-PERFORMANCE AND ADAPTIVE COMPUTING LEADER —
|
AMD COMPLETES ACQUISITION OF XILINX
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-26 16:20:00
| null |
SAN JOSE, CALIF.--(BUSINESS WIRE)--XILINX REPORTS RECORD REVENUE OF $1.01 BILLION IN FISCAL THIRD QUARTER
|
XILINX REPORTS RECORD REVENUE OF $1.01 BILLION IN FISCAL THIRD QUARTER
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-27 16:20:00
| null |
SAN JOSE, CALIF.--(BUSINESS WIRE)--XILINX REPORTS RECORD REVENUE IN FISCAL SECOND QUARTER 2022
|
XILINX REPORTS RECORD REVENUE IN FISCAL SECOND QUARTER 2022
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-07 09:01:00
| null |
SAN JOSE, CALIF.--(BUSINESS WIRE)-- #5G--XILINX IS MAKING NUMEROUS MARKET ANNOUNCEMENTS IN CONJUNCTION WITH XILINX ADAPT 2021, WHICH IS TAKING PLACE SEPTEMBER 7-16.
|
XILINX DATA CENTER, 5G AND CORE VERTICAL MARKETS IN THE SPOTLIGHT AT XILINX ADAPT 2021 VIRTUAL TECHNOLOGY CONFERENCE
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-31 09:00:00
| null |
SAN JOSE, CALIF. & SHANGHAI--(BUSINESS WIRE)-- #ADAS--XILINX AND MOTOVIS ARE COLLABORATING ON A HARDWARE AND SOFTWARE SOLUTION TO FURTHER AUTOMOTIVE FORWARD CAMERA INNOVATION.
|
XILINX AND MOTOVIS INTRODUCE COMPLETE HARDWARE AND SOFTWARE SOLUTION TO FURTHER AUTOMOTIVE FORWARD CAMERA INNOVATION
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-07-14 09:00:00
| null |
SAN JOSE, CALIF.--(BUSINESS WIRE)-- #CLOUD--XILINX INTRODUCES THE VERSAL HBM ADAPTIVE COMPUTE ACCELERATION PLATFORM (ACAP), THE NEWEST SERIES IN THE VERSAL PORTFOLIO.
|
XILINX VERSAL HBM SERIES WITH INTEGRATED HIGH BANDWIDTH MEMORY TACKLES BIG DATA COMPUTE CHALLENGES IN THE NETWORK AND CLOUD
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-06-10 03:01:00
| null |
SAN JOSE, CALIF.--(BUSINESS WIRE)-- #ACQUISITION--XILINX ANNOUNCED THAT IT HAS ACQUIRED SILEXICA, A PRIVATELY-HELD PROVIDER OF C/C++ PROGRAMMING AND ANALYSIS TOOLS.
|
XILINX ACQUIRES SILEXICA TO BROADEN ITS DEVELOPER BASE
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-06-09 09:00:00
| null |
SAN JOSE, CALIF.--(BUSINESS WIRE)-- #ACAP--XILINX INTRODUCED THE VERSAL™ AI EDGE SERIES, DESIGNED TO ENABLE AI INNOVATION FROM THE EDGE TO THE ENDPOINT.
|
XILINX EXTENDS EDGE COMPUTE LEADERSHIP WITH WORLD'S HIGHEST AI PERFORMANCE-PER-WATT
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-04 16:20:00
| null |
SAN JOSE, CALIF.--(BUSINESS WIRE)--XILINX REPORTS FISCAL FOURTH QUARTER AND FISCAL YEAR 2021 RESULTS
|
XILINX REPORTS FISCAL FOURTH QUARTER AND FISCAL YEAR 2021 RESULTS
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-27 09:00:00
| null |
SAN JOSE, CALIF.--(BUSINESS WIRE)-- #AI--XILINX ANNOUNCED THAT ITS VERSAL AI CORE AND VERSAL PRIME SERIES DEVICES ARE NOW SHIPPING TO CUSTOMERS IN FULL PRODUCTION VOLUMES.
|
XILINX ANNOUNCES FULL PRODUCTION SHIPMENTS OF 7NM VERSAL AI CORE AND VERSAL PRIME SERIES DEVICES
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-20 09:00:00
| null |
SAN JOSE, CALIF.--(BUSINESS WIRE)-- #AI--XILINX INTRODUCED THE KRIA PORTFOLIO OF ADAPTIVE SYSTEM-ON-MODULES (SOMS), FOR ACCELERATING INNOVATION AND AI APPLICATIONS AT THE EDGE.
|
XILINX INTRODUCES KRIA PORTFOLIO OF ADAPTIVE SYSTEM-ON-MODULES FOR ACCELERATING INNOVATION AND AI APPLICATIONS AT THE EDGE
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-13 09:00:00
| null |
RICHARDSON, TEXAS & SAN JOSE, CALIF.--(BUSINESS WIRE)--MAVENIR AND XILINX COLLABORATE TO BRING TO MARKET A UNIFIED 4G/5G O-RAN MASSIVE MIMO (MMIMO) PORTFOLIO TO ENABLE OPEN RAN DEPLOYMENTS
|
MAVENIR AND XILINX COLLABORATE TO BRING TO MARKET OPEN RAN MASSIVE MIMO PORTFOLIO
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-16 09:00:00
| null |
SAN JOSE, CALIF.--(BUSINESS WIRE)-- #ARTIX--XILINX HAS EXPANDED ITS ULTRASCALE+™ PORTFOLIO FOR NEW MARKETS AND APPLICATIONS THAT REQUIRE ULTRA-COMPACT AND INTELLIGENT EDGE SOLUTIONS.
|
XILINX EXPANDS INTO NEW APPLICATIONS WITH COST-OPTIMIZED ULTRASCALE+ PORTFOLIO FOR ULTRA-COMPACT, HIGH-PERFORMANCE EDGE COMPUTE
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-04 22:34:00
| null |
NEW YORK, MARCH 4, 2021 /PRNEWSWIRE/ -- NOTICE IS HEREBY GIVEN THAT MONTEVERDE & ASSOCIATES PC HAS FILED A CLASS ACTION LAWSUIT IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA, CASE NO. 3:21-CV-01108-JD, ON BEHALF OF COMMON SHAREHOLDERS OF XILINX, INC....
|
MONTEVERDE & ASSOCIATES PC FILES CLASS ACTION LAWSUIT ON BEHALF OF SHAREHOLDERS OF XILINX, INC. IN THE NORTHERN DISTRICT OF CALIFORNIA
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-02-23 09:00:00
| null |
SAN JOSE, CALIF.--(BUSINESS WIRE)-- #AI--XILINX ANNOUNCED A RANGE OF NEW DATA CENTER PRODUCTS AND SOLUTIONS, INCLUDING A NEW FAMILY OF ALVEO SMARTNICS.
|
XILINX REVOLUTIONIZES THE MODERN DATA CENTER WITH SOFTWARE-DEFINED, HARDWARE ACCELERATED ALVEO SMARTNICS
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-01-27 16:20:00
| null |
SAN JOSE, CALIF.--(BUSINESS WIRE)--XILINX REPORTS THIRD QUARTER FISCAL YEAR 2021 RESULTS
|
XILINX REPORTS THIRD QUARTER FISCAL YEAR 2021 RESULTS
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-10-28 20:15:00
| null |
NEW YORK, OCT. 28, 2020 /PRNEWSWIRE/ -- WEISSLAW LLP IS INVESTIGATING POSSIBLE BREACHES OF FIDUCIARY DUTY AND OTHER VIOLATIONS OF LAW BY THE BOARD OF DIRECTORS OF XILINX, INC. ("XLNX" OR THE "COMPANY") (NASDAQ: XLNX) IN CONNECTION WITH THE PROPOSED ACQUISITION OF THE COMPANY BY ADVANCED...
|
SHAREHOLDER ALERT: WEISSLAW LLP INVESTIGATES XILINX, INC.
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-10-27 12:05:00
| null |
NEW YORK, OCT. 27, 2020 /PRNEWSWIRE/ -- ROWLEY LAW PLLC IS INVESTIGATING POTENTIAL SECURITIES LAW VIOLATIONS BY XILINX, INC. (NASDAQ: XLNX) AND ITS BOARD OF DIRECTORS CONCERNING THE PROPOSED ACQUISITION OF THE COMPANY BY ADVANCED MICRO DEVICES, INC. (NASDAQ: AMD). STOCKHOLDERS WILL...
|
ALERT: ROWLEY LAW PLLC IS INVESTIGATING PROPOSED ACQUISITION OF XILINX, INC.
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-10-27 09:58:00
| null |
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLP, A GLOBAL INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER THE SALE OF XILINX, INC. (NASDAQ: XLNX) TO ADVANCED MICRO DEVICES, INC. (“AMD”) FOR 1.7234 SHARES OF AMD COMMON STOCK FOR EACH SHARE OF XILINX COMMON STOCK IS FAIR TO XILINX SHAREHOLDERS. ON BEHALF OF XILINX SHAREHOLDERS, HALPER SADEH LLP MAY SEEK INCREASED CONSIDERATION FOR SHAREHOLDERS, ADDITIONAL DISCLOSURES AND INFORMATION CONCERNING THE PROPOSED TRANSACTION, OR OTHER RELIEF AND BENEFITS
|
XILINX MERGER INVESTIGATION: HALPER SADEH LLP ANNOUNCES INVESTIGATION INTO WHETHER THE SALE OF XILINX, INC. IS FAIR TO SHAREHOLDERS; INVESTORS ARE ENCOURAGED TO CONTACT THE FIRM – XLNX
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-10-27 09:00:00
| null |
SAN JOSE, CALIF.--(BUSINESS WIRE)-- #5G--XILINX INTRODUCES ZYNQ RFSOC DFE, A CLASS OF ADAPTIVE RADIO PLATFORMS DESIGNED TO MEET THE EVOLVING STANDARDS OF 5G NR WIRELESS APPLICATIONS.
|
XILINX INTRODUCES BREAKTHROUGH ZYNQ RFSOC DFE FOR MASS 5G RADIO DEPLOYMENTS
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-07-30 19:30:00
| null |
QTRLY EARNINGS PER SHARE $0.38; QTRLY NON-GAAP EARNINGS PER SHARE $0.65.SEES Q2 REVENUE $730 MILLION TO $780 MILLION.QTRLY REVENUE $727 MILLION VERSUS $850 MILLION.SEES Q2 GAAP GROSS MARGIN 68.5% TO 71.5%; SEES Q2 NON-GAAP GROSS MARGIN 69.5% - 72.5%.Q1 EARNINGS PER SHARE VIEW $0.56, REVENUE VIEW $725.6 MILLION -- REFINITIV IBES DATA.Q2 REVENUE VIEW $730.3 MILLION -- REFINITIV IBES DATA.SEES Q2 GAAP OPERATING EXPENSES $326 MILLION - $340 MILLION.
|
XILINX INC REPORTS QTRLY EPS $0.38
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-06-29 18:30:00
| null |
XILINX UPDATES FINANCIAL GUIDANCE FOR FIRST QUARTER FISCAL 2021.RAISING MIDPOINT FOR REVENUE AND NARROWING OVERALL GUIDANCE RANGES FOR JUNE QUARTER.EXPECT Q2 REVENUES TO BE, APPROXIMATELY, IN LINE WITH Q1.SEES Q1 REVENUES $720M - $734M.SEES Q1 GAAP GROSS MARGIN ABOUT 67% - 68%.SEES Q1 GAAP OPERATING EXPENSES $314M - $320M.WHILE CO SAW SOME COVID-19 RELATED IMPACTS DURING JUNE QUARTER, BUSINESS HAS GENERALLY PERFORMED WELL OVERALL.XILINX- SEES Q1 NON-GAAP GROSS MARGIN ABOUT 68% - 69%.STRONGER-THAN-EXPECTED REVENUE IN WIRED & WIRELESS, DATA CENTER GROUP OFFSET WEAKER-THAN-EXPECTED REVENUE IN CONSUMER-ORIENTED END MARKETS IN QUARTER.XILINX- SEES Q1 NON-GAAP OPERATING EXPENSES OF ABOUT $310 MILLION - $316 MILLION.XILINX - PORTION OF REVENUE STRENGTH IN QUARTER DUE TO CUSTOMERS ACCELERATING ORDERS ON CHANGES TO U.S. RESTRICTIONS ON SALES TO INTERNATIONAL CUSTOMERS.Q1 REVENUE VIEW $690.3 MILLION -- REFINITIV IBES DATA.
|
XILINX SEES Q1 REVENUE BETWEEN $720 MLN- $734 MLN
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-05-12 20:30:00
| null |
XILINX INC ANNOUNCES PRICING OF $750 MILLION OF SENIOR NOTES.XILINX - HAS PRICED OFFERING OF $750 MILLION OF ITS 2.375% SENIOR NOTES DUE 2030 AT A PRICE TO PUBLIC OF 99.973% OF THEIR FACE VALUE.
|
XILINX ANNOUNCES PRICING OF $750 MILLION OF SENIOR NOTES
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-05-08 19:30:00
| null |
XILINX INC FILES FOR POTENTIAL MIXED SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILING.
|
XILINX INC FILES FOR POTENTIAL MIXED SHELF OFFERING; SIZE NOT DISCLOSED
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-04-22 18:30:00
| null |
XILINX REPORTS FISCAL FOURTH QUARTER AND FISCAL YEAR 2020 RESULTS.Q4 NON-GAAP EARNINGS PER SHARE $0.78.Q4 GAAP EARNINGS PER SHARE $0.65.Q4 EARNINGS PER SHARE ESTIMATE $0.69 -- REFINITIV IBES DATA.Q4 REVENUE $756 MILLION VERSUS REFINITIV IBES ESTIMATE OF $752.5 MILLION.BELIEVE IT IS PRUDENT TO PROVIDE ONLY QUARTERLY GUIDANCE AT THIS TIME.SEES Q1 2021 REVENUES $660 MILLION - $720 MILLION.SEES Q1 2021 GAAP GROSS MARGIN 67% - 69%.SEES Q1 2021 NON-GAAP GROSS MARGIN 68% - 70%.SEES Q1 2021 GAAP OPERATING EXPENSES $312 MILLION - $316 MILLION.SEES Q1 2021 NON-GAAP OPERATING EXPENSES $307 MILLION - $311 MILLION.Q1 REVENUE VIEW $738.8 MILLION -- REFINITIV IBES DATA.DECLARED A QUARTERLY CASH DIVIDEND OF $0.38 PER OUTSTANDING SHARE.
|
XILINX REPORTS Q4 EARNINGS PER SHARE $0.65
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-04-09 11:30:00
| null |
XILINX APPOINTS BRICE HILL AS CHIEF FINANCIAL OFFICER.XILINX INC - APPOINTED BRICE HILL TO POSITION OF EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER EFFECTIVE IMMEDIATELY.
|
XILINX APPOINTS BRICE HILL AS CHIEF FINANCIAL OFFICER
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-03-18 07:30:00
| null |
REACHES STRATEGIC COLLABORATION AGREEMENT WITH ALTIOSTAR, GIGATERA COMMUNICATIONS, INTEL, SUPERMICRO AND XILINX, INC. TO DEVELOP OPEN RAN TECHNOLOGIES IN 4G AND 5G.TO LAUNCH FIRST 4G AND 5G OPEN RAN TRIALS IN THE UK, GERMANY, SPAIN AND BRAZIL THIS YEAR.
|
TELEFONICA REACHES COLLABORATION AGREEMENT TO DEVELOP OPEN RAN IN 4G AND 5G
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-01-21 10:30:00
| null |
XILINX FILES PATENT INFRINGEMENT LAWSUIT AGAINST ANALOG DEVICES.XILINX - FILED CLAIMS AGAINST ANALOG DEVICES, ASSERTING INFRINGEMENT OF 8 UNITED STATES PATENTS IN U.S. DISTRICT COURT FOR DISTRICT OF DELAWARE.
|
XILINX FILES PATENT INFRINGEMENT LAWSUIT AGAINST ANALOG DEVICES
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-12-05 18:30:00
| null |
XILINX ISSUES STATEMENT IN RESPONSE TO ANALOG DEVICES PATENT INFRINGEMENT LAWSUIT.XILINX - INTEND TO DEFEND AGAINST ANALOG DEVICES LAWSUIT.
|
XILINX ISSUES STATEMENT IN RESPONSE TO ANALOG DEVICES PATENT INFRINGEMENT LAWSUIT
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-12-04 22:30:00
| null |
ANALOG DEVICES, INC. ANNOUNCED THAT IT HAS FILED A PATENT INFRINGEMENT LAWSUIT AGAINST XILINX, INC. THE LAWSUIT FOCUSES ON THE UNAUTHORIZED USE BY XILINX OF SEVERAL IMPORTANT ADI PATENTS RELATING TO CONVERTER TECHNOLOGY IN AT LEAST TWO OF XILINX’S HIGH END ZYNQ ULTRASCALE + RFSOC PRODUCTS. THE LAWSUIT, FILED IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE, SEEKS DAMAGES AND AN INJUNCTION THAT PREVENTS XILINX FROM SELLING ANY PRODUCTS THAT INFRINGE ADI’S PATENTS.
|
ANALOG DEVICES, INC. FILES PATENT INFRINGEMENT LAWSUIT AGAINST XILINX, INC
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-11 22:30:00
| null |
XILINX, INC. ANNOUNCED THE EXPANSION OF ITS AUTOMOTIVE-QUALIFIED 16 NANOMETER (NM) FAMILY WITH TWO NEW DEVICES – THE XILINX® AUTOMOTIVE (XA) ZYNQ® ULTRASCALE+™ MPSOC 7EV AND 11EG. THESE TWO NEW PARTS DELIVER THE HIGHEST PROGRAMMABLE CAPACITY, PERFORMANCE AND I/O CAPABILITIES ENABLING HIGH-SPEED, DATA AGGREGATION, PRE-PROCESSING, AND DISTRIBUTION (DAPD), AS WELL AS COMPUTE ACCELERATION FOR L2+ TO L4 ADVANCED DRIVER-ASSISTANCE SYSTEMS (ADAS) AND AUTONOMOUS DRIVING (AD) APPLICATIONS. WITH THESE NEW ADDITIONS, XILINX NOW OFFERS THE WORLD'S HIGHEST LEVEL OF SILICON INTEGRATION THAT MEETS THE SAFETY, QUALITY AND RELIABILITY REQUIREMENTS FOR AUTOMOTIVE, WITH A COMPREHENSIVE LINE OF PRODUCTS SCALING FROM SMALL DEVICES POWERING EDGE SENSORS TO NEW HIGH-PERFORMANCE DEVICES FOR CENTRALIZED DOMAIN CONTROLLERS. THE NEW XA ZYNQ ULTRASCALE+ MPSOC 7EV AND 11EG DEVICES WERE DEVELOPED AS A RESULT OF CUSTOMER DEMAND. THE DEVICES OFFER OVER 650,000 PROGRAMMABLE LOGIC CELLS – AND NEARLY 3,000 DSP SLICES, WHICH IS 2.5X INCREASE VERSUS THE PREVIOUS LARGEST DEVICE. IN ADDITION, THE XA 7EV CONTAINS A VIDEO CODEC UNIT FOR H.264/H.265 ENCODE AND DECODE, WHILE THE XA 11EG INCLUDES 32 12.5GB/S TRANSCEIVERS AND PROVIDES FOUR PCIE® GEN3X16 BLOCKS. THE ADDITION OF THESE HIGH-PERFORMANCE DEVICES TO THE XA PORTFOLIO ENABLES CARMAKERS, ROBOTAXI DEVELOPERS, AND TIER-1 SUPPLIERS TO PERFORM THE DAPD AND COMPUTE ACCELERATION IN A POWER ENVELOPE THAT ALLOWS FOR SCALABLE PRODUCTION DEPLOYMENTS FOR AD VEHICLES. THE XA ZYNQ ULTRASCALE+ MPSOC PORTFOLIO IS QUALIFIED ACCORDING TO AEC-Q100 TEST SPECIFICATIONS AND INTEGRATES BOTH XILINX PROGRAMMABLE LOGIC AND A 64-BIT QUAD-CORE ARM® CORTEX®™-A53 AND DUAL-CORE ARM CORTEX-R5 BASED PROCESSING SYSTEM THAT IS CERTIFIED TO ASIL-C LEVEL IN THE LOW POWER DOMAIN. THE COMBINATION OF THESE FEATURES, PAIRED WITH THE HIGH DATA THROUGHPUT CAPABILITY OF THE NEW DEVICES, ACCELERATE THE DEPLOYMENT OF AUTONOMOUS VEHICLES ON THE ROAD TODAY. TO DATE, XILINX HAS SHIPPED MORE THAN 67 MILLION AUTO-QUALIFIED SOLUTIONS FOR ADAS SYSTEMS AND AD PRODUCTION VEHICLES TO OVER 200 AUTOMOTIVE COMPANIES INCLUDING GLOBAL TIER-1 SUPPLIERS, OEMS AND START-UPS. THE NEW XA ZYNQ ULTRASCALE+ MPSOC DEVICES ARE AVAILABLE FOR ORDER TODAY. FULL TECHNICAL DETAILS ON THE XA FAMILY CAN BE FOUND HERE. ALL XA DEVICES ARE SUPPORTED BY VITIS™ AND VITIS AI, THE COMPANY'S NEW UNIFIED SOFTWARE PLATFORM THAT ENABLES A BROAD RANGE OF DEVELOPERS TO TAKE ADVANTAGE OF THE POWER OF HARDWARE ADAPTABILITY.
|
XILINX, INC. ANNOUNCES HIGHEST PERFORMANCE ADAPTIVE DEVICES FOR ADVANCED ADAS AND AD APPLICATIONS
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-05 22:30:00
| null |
THE SEEING MACHINES FOVIO DRIVER MONITORING CHIP HAS BEEN BOLSTERED BY A RENEWED SUPPLY AGREEMENT WITH ITS SILICON SUPPLY PARTNER, XILINX, INC. XILINX, THE LEADER IN ADAPTIVE AND INTELLIGENT COMPUTING, IS COLLABORATING WITH SEEING MACHINES TO SUPPLY SEMI-CUSTOM VERSIONS OF ITS AUTOMOTIVE-GRADE DEVICES, SUPPORTING SEEING MACHINES' FOVIO CHIP SOLUTION FOR THE AUTOMOTIVE MARKET. THE FOVIO CHIP IS CURRENTLY COMMITTED TO THREE ONGOING AUTOMOTIVE OEM PROGRAMS, TWO IN NORTH AMERICA AND ONE IN CHINA. THE AGREEMENT EXTENDS THE EXISTING SUPPLIER PARTNERSHIP BETWEEN SEEING MACHINES AND XILINX, WHERE XILINX WILL NOW PROVIDE THE FOVIO CHIP DIRECTLY TO AUTOMOTIVE TIER 1 CUSTOMERS THAT ARE PRE-APPROVED BY SEEING MACHINES. BY XILINX SUPPLYING SILICON TO SEEING MACHINES' FOVIO CHIP CUSTOMERS, SUPPLY CHAIN COMPLEXITIES WILL BE REDUCED, AS WELL AS ASSOCIATED RISKS AND COSTS.
|
SEEING MACHINES AND XILINX COLLABORATE TO SUPPLY FOVIO CHIP
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-31 22:30:00
| null |
XILINX, INC. AND SK TELECOM ANNOUNCED THAT SK TELECOM HAS ADOPTED XILINX®ALVEO DATACENTER ACCELERATOR CARDS TO POWER A REAL-TIME AI-BASED PHYSICAL INTRUSION AND THEFT DETECTION SERVICE. SK TELECOM'S AI INFERENCE ACCELERATOR (AIX) IMPLEMENTED ON XILINX ALVEO CARDS PROVIDES EFFICIENT AND ACCURATE PHYSICAL INTRUSION DETECTION USING DEEP NEURAL NETWORKS. ADT CAPS CO., LTD., SOUTH KOREA'S SECOND LARGEST PHYSICAL SECURITY COMPANY, LICENSES AND COMMERCIALLY DEPLOYS THE PHYSICAL INTRUSION DETECTION SERVICE. SK TELECOM'S AI-BASED PHYSICAL INTRUSION DETECTION SERVICE, T VIEWTM, MONITORS HUNDREDS OF THOUSANDS OF CUSTOMERS' COMMERCIAL AND HOME CAMERA SYSTEMS IN REAL-TIME AND DISPATCHES SECURITY GUARDS UNDER PHYSICAL INTRUSION CIRCUMSTANCES. PROCESSING A LARGE VOLUME OF DATA FROM THOUSANDS OF CAMERAS USING DEEP NEURAL NETWORKS NECESSITATES A POWERFUL AI ACCELERATOR THAT CAN PROVIDE ENOUGH THROUGHPUT AND ACCURACY. T VIEW USES SK TELECOM'S AI INFERENCE ACCELERATOR (AIX), IMPLEMENTED ON XILINX ALVEO U250 CARDS. RUNNING ON SERVERS IN SK TELECOM'S DATA CENTER, ALVEO U250 CARDS HAVE DEMONSTRATED HIGH THROUGHPUT AND ACCURACY IN THEFT DETECTION SERVICES. THE CARDS DELIVER LOWER DETECTION LATENCY AND HAVE ACHIEVED SUPERIOR THROUGHPUT (FRAMES PER SECOND) COMPARED TO LEADING GPUS AND HAVE PROVEN TO BE MORE COST EFFECTIVE. THE IMPROVED THROUGHPUT AND ACCURACY DELIVERED BY ALVEO CARDS MEANS MORE CUSTOMERS WILL HAVE ACCESS TO REAL-TIME, AI-BASED SECURITY SERVICES, AND A MORE RELIABLE PROTECTION AGAINST SECURITY THREATS. XILINX ALVEO ACCELERATOR CARDS ARE DESIGNED TO MEET THE PERFORMANCE AND FLEXIBILITY NEEDS OF DATA CENTER AI WORKLOADS, PROVIDING 10X HIGHER PERFORMANCE1 FOR AI-BASED SPEECH TRANSLATION AND OVER 3X HIGHER THROUGHOUT FOR VIDEO ANALYTICS PIPELINES COMPARED TO GPUS. BUILT ON THE XILINX® 16NM ULTRASCALE+™ ARCHITECTURE, ALVEO ACCELERATORS ARE ADAPTABLE TO CHANGING ALGORITHMS AND ACCELERATION REQUIREMENTS, ENABLING DOMAIN SPECIFIC ARCHITECTURES THAT OPTIMIZE PERFORMANCE FOR A RANGE OF WORKLOADS WITHOUT CHANGING HARDWARE, AND WHILE REDUCING OVERALL COST OF OWNERSHIP. THE COMMERCIAL DEPLOYMENT OF XILINX ALVEO CARDS IN SK TELECOM'S DATA CENTER FOR AI SERVICES BUILDS UPON THE ANNOUNCEMENT AND SUCCESS OF SK TELECOM'S AUTOMATED SPEECH-RECOGNITION (ASR) APPLICATION POWERED BY XILINX FPGAS TO ACCELERATE NUGU, A VOICE-ACTIVATED ASSISTANT. SK TELECOM'S AIX ACCELERATOR, IMPLEMENTED ON THE ALVEO U250, AND THE T VIEW SERVICE ARE CURRENTLY AVAILABLE IN SOUTH KOREA AND ARE EXPECTED TO BE AVAILABLE GLOBALLY IN FALL 2020. THE T VIEW IS ALSO EXPECTED TO BE COMMERCIALLY AVAILABLE AS A REBRANDED SOLUTION FROM OTHER SK TELECOM LICENSED COMPANIES.
|
XILINX ALVEO ACCELERATORS POWER SK TELECOM'S REAL-TIME AI-BASED PHYSICAL INTRUSION AND THEFT DETECTION SERVICE
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-23 18:30:00
| null |
XILINX REPORTS FISCAL SECOND QUARTER 2020 RESULTS.Q2 NON-GAAP EARNINGS PER SHARE $0.94.Q2 GAAP EARNINGS PER SHARE $0.89.Q2 REVENUE $833 MILLION VERSUS REFINITIV IBES ESTIMATE OF $824.8 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $0.89 -- REFINITIV IBES DATA.BOARD OF DIRECTORS APPROVES SHARE REPURCHASE AUTHORIZATION OF UP TO $1.0 BILLION.COMPANY NOW EXPECTS FULL YEAR REVENUE GROWTH OF APPROXIMATELY 6%.XILINX - SEES Q3 REVENUES $710 MILLION- $740 MILLION.SEES FISCAL YEAR 2020 GAAP REVENUES $3,210 MILLION-$3,280 MILLION.Q3 REVENUE VIEW $844.9 MILLION -- REFINITIV IBES DATA.SEES FISCAL YEAR 2020 GAAP GROSS MARGIN BETWEEN 65.5% - 67.5%.FY2020 REVENUE VIEW $3.40 BILLION -- REFINITIV IBES DATA.XILINX - Q3 AND 2020 GUIDANCE TAKES INTO ACCOUNT IMPACT FROM U.S. GOVERNMENT'S ANNOUNCED EXPORT RESTRICTION TO ONE OF OUR CUSTOMERS IN CHINA."FIRST HALF OF OUR CURRENT FISCAL YEAR REMAINED STRONG DESPITE IMPACT OF CONTINUED BUSINESS RESTRICTIONS RELATED TO HUAWEI".FOR FISCAL 2020, WE BELIEVE THAT Q3 WILL BE OUR LOW POINT.EXPECT TO SEE A RETURN TO SEQUENTIAL REVENUE GROWTH IN OUR Q4.
|
XILINX REPORTS FISCAL SECOND QUARTER 2020 RESULTS
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-22 22:30:00
| null |
THE XILINX, INC. BOARD OF DIRECTORS DECLARED A QUARTERLY CASH DIVIDEND OF $0.37 PER OUTSTANDING SHARE OF COMMON STOCK PAYABLE ON DECEMBER 3, 2019, TO ALL STOCKHOLDERS OF RECORD AT THE CLOSE OF BUSINESS ON NOVEMBER 12, 2019.
|
XILINX, INC. DECLARES QUARTERLY CASH DIVIDEND, PAYABLE ON DECEMBER 3, 2019
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-21 22:30:00
| null |
ON OCTOBER 22, 2019, THE COMPANY ANNOUNCED AN INCREASE IN ITS EQUITY BUYBACK PLAN. THE COMPANY INCREASES ITS AUTHORIZATION BY $1,000 MILLION.
|
XILINX, INC. ANNOUNCES AN INCREASE IN EQUITY BUYBACK.
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-16 22:30:00
| null |
AUPERA TECHNOLOGIES INC. ANNOUNCED THAT IT HAS RECEIVED A ROUND OF FUNDING FROM NEW INVESTOR, XILINX, INC. (NASDAQGS:XLNX) ON OCTOBER 17, 2019.
|
AUPERA TECHNOLOGIES INC. ANNOUNCED THAT IT HAS RECEIVED FUNDING FROM XILINX, INC.
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-08 22:30:00
| null |
XILINX, INC. PRESENTS AT WORLD SUMMIT AI, OCT-09-2019 12:15 PM. VENUE: TAETS PARK, ZAANDAM, NETHERLANDS. SPEAKERS: RAMINE ROANE, VP OF AI AND SOFTWARE.
|
XILINX, INC. PRESENTS AT WORLD SUMMIT AI, OCT-09-2019 12:15 PM
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-03 22:30:00
| null |
XILINX, INC. PRESENTS AT CREDIT SUISSE 23RD ANNUAL TECHNOLOGY CONFERENCE, DEC-02-2019 THROUGH DEC-05-2019. VENUE: THE PHOENICIAN, 6000 EAST CAMELBACK ROAD, SCOTTSDALE, ARIZONA, UNITED STATES. PRESENTATION DATE & SPEAKERS: DEC-04-2019, MATT POIRIER, SENIOR VP OF CORPORATE DEVELOPMENT & INVESTOR RELATIONS AND TREASURER. DEC-05-2019, MATT POIRIER, SENIOR VP OF CORPORATE DEVELOPMENT & INVESTOR RELATIONS AND TREASURER, REUBEN GALLEGOS, SENIOR DIRECTOR, IR.
|
XILINX, INC. PRESENTS AT CREDIT SUISSE 23RD ANNUAL TECHNOLOGY CONFERENCE, DEC-02-2019 THROUGH DEC-05-2019
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-01 16:30:00
| null |
XILINX SAYS COLLABORATING WITH MICROSOFT ON AZURE CLOUD COMPUTING SERVICE.
|
XILINX SAYS COLLABORATING WITH MICROSOFT ON AZURE CLOUD COMPUTING SERVICE
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-09-30 22:30:00
| null |
CORTICAL.IO GMBH ANNOUNCED THAT IT HAS RECEIVED A ROUND OF FUNDING FROM XILINX, INC. (NASDAQGS:XLNX) ON OCTOBER 1, 2019.
|
CORTICAL.IO GMBH ANNOUNCED THAT IT HAS RECEIVED FUNDING FROM XILINX, INC.
|
XLNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-05-25 17:01:00
| null |
ENCOURAGING PRELIMINARY ANTI-TUMOR ACTIVITY OBSERVED IN A PATIENT WITH PD-L1 NEGATIVE ADVANCED NON-SMALL CELL LUNG CANCER
|
XILIO THERAPEUTICS ANNOUNCES PRELIMINARY CLINICAL DATA FROM PHASE 1 TRIAL OF XTX101, A TUMOR-ACTIVATED, FC-ENHANCED ANTI-CTLA-4, IN PATIENTS WITH ADVANCED SOLID TUMORS
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-05-09 07:30:00
| null |
INITIATED PHASE 2 CLINICAL TRIAL FOR XTX202, A TUMOR-ACTIVATED IL-2 ANTICIPATE REPORTING PRELIMINARY PHASE 1 SAFETY, PK, PD, AND ANTI-TUMOR ACTIVITY DATA FOR XTX101, A TUMOR-ACTIVATED, FC-ENHANCED ANTI-CTLA-4, IN THE SECOND QUARTER OF 2023 ENDED FIRST QUARTER OF 2023 WITH $93.3 MILLION IN CASH AND CASH EQUIVALENTS, WITH CASH RUNWAY ANTICIPATED INTO THE END OF THE SECOND QUARTER OF 2024 WALTHAM, MASS., MAY 09, 2023 (GLOBE NEWSWIRE) -- XILIO THERAPEUTICS, INC. (NASDAQ: XLO), A CLINICAL-STAGE BIOTECHNOLOGY COMPANY DISCOVERING AND DEVELOPING TUMOR-ACTIVATED IMMUNO-ONCOLOGY THERAPIES FOR PEOPLE LIVING WITH CANCER, TODAY ANNOUNCED PIPELINE PROGRESS AND BUSINESS UPDATES AND REPORTED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2023.
|
XILIO THERAPEUTICS ANNOUNCES PIPELINE AND BUSINESS UPDATES AND FIRST QUARTER 2023 FINANCIAL RESULTS
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-04-03 16:05:00
| null |
WALTHAM, MASS., APRIL 03, 2023 (GLOBE NEWSWIRE) -- XILIO THERAPEUTICS, INC. (NASDAQ: XLO), A BIOTECHNOLOGY COMPANY DEVELOPING TUMOR-ACTIVATED IMMUNO-ONCOLOGY THERAPIES FOR PEOPLE LIVING WITH CANCER, TODAY ANNOUNCED THAT THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS GRANTED A NON-QUALIFIED STOCK OPTION TO PURCHASE 55,000 SHARES OF COMMON STOCK TO KEVIN BRENNAN, THE COMPANY'S NEWLY HIRED SENIOR VICE PRESIDENT, FINANCE AND ACCOUNTING. THE STOCK OPTION WAS GRANTED EFFECTIVE AS OF APRIL 1, 2023 UNDER XILIO THERAPEUTICS' 2022 INDUCEMENT STOCK INCENTIVE PLAN, AS AN INDUCEMENT MATERIAL TO MR. BRENNAN ENTERING INTO EMPLOYMENT WITH THE COMPANY IN ACCORDANCE WITH NASDAQ LISTING RULE 5635(C)(4).
|
XILIO THERAPEUTICS ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-02 16:05:00
| null |
INITIAL CLINICAL DATA FROM XTX101, XTX202 AND XTX301 CLINICAL TRIALS ANTICIPATED IN 2023
|
XILIO THERAPEUTICS ANNOUNCES PIPELINE AND BUSINESS UPDATES FOR THE FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-11-23 07:30:00
| null |
WALTHAM, MASS., NOV. 23, 2022 (GLOBE NEWSWIRE) -- XILIO THERAPEUTICS, INC. (NASDAQ: XLO), A BIOTECHNOLOGY COMPANY DEVELOPING TUMOR-ACTIVATED IMMUNO-ONCOLOGY THERAPIES FOR PEOPLE LIVING WITH CANCER, TODAY ANNOUNCED THAT THE COMPANY WILL HOST A LIVE VIRTUAL PROGRAM ON THURSDAY, DECEMBER 1, 2022, AT 12:30 P.M. ET SPOTLIGHTING XILIO'S CLINICAL-STAGE MOLECULE XTX301, A TUMOR-ACTIVATED, ENGINEERED IL-12.
|
XILIO THERAPEUTICS TO HOST LIVE VIRTUAL PROGRAM SPOTLIGHTING XTX301, A TUMOR-ACTIVATED IL-12
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-11-09 07:30:00
| null |
XTX202, A TUMOR-ACTIVATED IL‑2, SUCCESSFULLY REACHED TARGET DOSE RANGE OF 1 MG/KG IN ONGOING PHASE 1 CLINICAL TRIAL; PRELIMINARY EVIDENCE OF INCREASED CD8+ EFFECTOR T CELLS AND NK CELLS OBSERVED WITH NO SIGNS OF VASCULAR LEAK SYNDROME
|
XILIO THERAPEUTICS ANNOUNCES PIPELINE AND BUSINESS UPDATES AND THIRD QUARTER 2022 FINANCIAL RESULTS
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-09-15 16:05:00
| null |
JOHN MARAGANORE, PH.D., FORMER FOUNDING CEO OF ALNYLAM PHARMACEUTICALS, JOINS AS A STRATEGIC ADVISOR JOHN MARAGANORE, PH.D., FORMER FOUNDING CEO OF ALNYLAM PHARMACEUTICALS, JOINS AS A STRATEGIC ADVISOR
|
XILIO THERAPEUTICS APPOINTS TOMAS J. HEYMAN TO BOARD OF DIRECTORS
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-08-09 07:30:00
| null |
XTX101, TUMOR-SELECTIVE ANTI-CTLA-4, HAS SUCCESSFULLY REACHED DOSE LEVELS EXCEEDING THE TARGET DOSE WITH LIMITED ACTIVE (UNMASKED) MOLECULE IN THE PERIPHERY IN ONGOING PHASE 1 CLINICAL TRIAL
|
XILIO THERAPEUTICS ANNOUNCES ENCOURAGING PRELIMINARY PHASE 1 DOSE-ESCALATION DATA FOR XTX101, A TUMOR-SELECTIVE ANTI-CTLA-4, AND REPORTS PIPELINE AND BUSINESS UPDATES AND SECOND QUARTER 2022 FINANCIAL RESULTS
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-06-16 07:30:00
| null |
PAUL CLANCY ELECTED AS CHAIR OF THE BOARD OF DIRECTORS
|
XILIO THERAPEUTICS ANNOUNCES PROMOTION OF MARTIN HUBER, M.D., TO PRESIDENT
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-05-12 07:30:00
| null |
CLINICAL PROGRAMS FOR XTX202, A TUMOR-SELECTIVE IL-2, AND XTX101, A TUMOR-SELECTIVE ANTI-CTLA-4, CONTINUE TO ADVANCE WITH PRELIMINARY DATA ANTICIPATED IN 2022
|
XILIO THERAPEUTICS REPORTS PIPELINE AND BUSINESS HIGHLIGHTS AND FIRST QUARTER 2022 FINANCIAL RESULTS
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-03-01 06:30:00
| null |
INITIAL PHASE 1 DATA READOUTS FROM CLINICAL TRIALS OF XTX101 AND XTX202 ANTICIPATED IN 2022
|
XILIO THERAPEUTICS REPORTS PIPELINE AND BUSINESS PROGRESS AND FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-02-28 06:30:00
| null |
WALTHAM, MASS., FEB. 28, 2022 (GLOBE NEWSWIRE) -- XILIO THERAPEUTICS, INC. (NASDAQ: XLO), A BIOTECHNOLOGY COMPANY DEVELOPING TUMOR-SELECTIVE IMMUNO-ONCOLOGY THERAPIES FOR PEOPLE LIVING WITH CANCER, TODAY ANNOUNCED THAT RENÉ RUSSO, PHARM.D., PRESIDENT AND CHIEF EXECUTIVE OFFICER, WILL PARTICIPATE IN A VIRTUAL PANEL TITLED, “NOVEL IO PANEL,” DURING THE COWEN 42ND ANNUAL HEALTHCARE CONFERENCE ON MONDAY, MARCH 7, 2022, AT 10:30 A.M. ET.
|
XILIO THERAPEUTICS TO PARTICIPATE IN THE COWEN 42ND ANNUAL HEALTHCARE CONFERENCE
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-02-03 06:30:00
| null |
WALTHAM, MASS., FEB. 03, 2022 (GLOBE NEWSWIRE) -- XILIO THERAPEUTICS, INC. (NASDAQ: XLO), A BIOTECHNOLOGY COMPANY DEVELOPING TUMOR-SELECTIVE IMMUNO-ONCOLOGY THERAPIES FOR PEOPLE LIVING WITH CANCER, TODAY ANNOUNCED THAT RENÉ RUSSO, PHARM. D., PRESIDENT AND CHIEF EXECUTIVE OFFICER, AND MARTY HUBER, M.D., PRESIDENT OF RESEARCH AND DEVELOPMENT AND CHIEF MEDICAL OFFICER OF XILIO THERAPEUTICS, WILL PARTICIPATE IN A VIRTUAL FIRESIDE CHAT DURING THE GUGGENHEIM 4TH ANNUAL ONCOLOGY DAY ON THURSDAY, FEBRUARY 10, 2022, AT 8:30 A.M. ET.
|
XILIO THERAPEUTICS TO PARTICIPATE IN THE GUGGENHEIM 4TH ANNUAL ONCOLOGY DAY
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-20 07:30:00
| null |
WALTHAM, MASS., JAN. 20, 2022 (GLOBE NEWSWIRE) -- XILIO THERAPEUTICS, INC. (NASDAQ: XLO), A BIOTECHNOLOGY COMPANY DEVELOPING TUMOR-SELECTIVE IMMUNO-ONCOLOGY THERAPIES FOR PEOPLE LIVING WITH CANCER, TODAY ANNOUNCED THAT THE FIRST PATIENT HAS BEEN DOSED IN THE COMPANY'S PHASE 1/2 CLINICAL TRIAL EVALUATING XTX202 FOR THE TREATMENT OF SOLID TUMORS. XTX202 IS A MODIFIED FORM OF IL-2 THAT IS DESIGNED TO LOCALIZE ACTIVITY IN THE TUMOR MICROENVIRONMENT (TME), WITH THE GOAL OF OVERCOMING THE KNOWN TOLERABILITY CHALLENGES OF EXISTING IL-2 THERAPIES WHILE ACHIEVING ENHANCED ANTI-TUMOR ACTIVITY.
|
XILIO THERAPEUTICS ANNOUNCES INITIATION OF PATIENT DOSING IN PHASE 1/2 CLINICAL TRIAL OF XTX202 FOR THE TREATMENT OF PATIENTS WITH SOLID TUMORS
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-06 07:30:00
| null |
WALTHAM, MASS., JAN. 06, 2022 (GLOBE NEWSWIRE) -- XILIO THERAPEUTICS, INC. (NASDAQ: XLO), A BIOTECHNOLOGY COMPANY DEVELOPING TUMOR-SELECTIVE IMMUNO-ONCOLOGY THERAPIES FOR PEOPLE LIVING WITH CANCER, TODAY ANNOUNCED THE APPOINTMENT OF YUAN XU, PH.D., TO ITS BOARD OF DIRECTORS.
|
XILIO THERAPEUTICS APPOINTS YUAN XU, PH.D., TO ITS BOARD OF DIRECTORS
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-12-02 07:30:00
| null |
ANTICIPATE FIRST PATIENT DOSING IN PHASE 1/2 CLINICAL TRIAL FOR XTX202, A TUMOR-SELECTIVE IL-2, IN FIRST QUARTER OF 2022
|
XILIO THERAPEUTICS REPORTS PIPELINE AND BUSINESS PROGRESS AND THIRD QUARTER 2021 FINANCIAL RESULTS
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-26 16:05:00
| null |
WALTHAM, MASS., OCT. 26, 2021 (GLOBE NEWSWIRE) -- XILIO THERAPEUTICS, INC. (XILIO) A BIOTECHNOLOGY COMPANY DEVELOPING TUMOR-SELECTIVE IMMUNO-ONCOLOGY THERAPIES FOR PATIENTS WITH CANCER, TODAY ANNOUNCED THE CLOSING OF ITS PREVIOUSLY ANNOUNCED INITIAL PUBLIC OFFERING OF 7,353,000 SHARES OF ITS COMMON STOCK AT A PRICE TO THE PUBLIC OF $16.00 PER SHARE. THE AGGREGATE GROSS PROCEEDS TO XILIO FROM THE OFFERING WERE APPROXIMATELY $117.6 MILLION, BEFORE DEDUCTING UNDERWRITING DISCOUNTS AND COMMISSIONS AND ESTIMATED OFFERING EXPENSES PAYABLE BY XILIO. IN ADDITION, XILIO HAS GRANTED THE UNDERWRITERS A 30-DAY OPTION TO PURCHASE UP TO AN ADDITIONAL 1,102,950 SHARES OF ITS COMMON STOCK AT THE INITIAL PUBLIC OFFERING PRICE LESS UNDERWRITING DISCOUNTS AND COMMISSIONS.
|
XILIO THERAPEUTICS ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-21 20:22:00
| null |
WALTHAM, MASS.--(BUSINESS WIRE)--XILIO THERAPEUTICS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING.
|
XILIO THERAPEUTICS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING
|
XLO
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-17 14:26:00
| null |
NEW YORK--(BUSINESS WIRE)--AVORO CAPITAL ADVISORS (“AVORO”), A LONG-TERM AND COLLABORATIVE INVESTOR IN LIFE SCIENCES AND BIOTECHNOLOGY COMPANIES, TOGETHER WITH CERTAIN OF ITS AFFILIATES AND MANAGED FUNDS (“AVORO,” “WE” OR “US”) BENEFICIALLY OWNS APPROXIMATELY 7% OF ACCELERON PHARMA INC. (NASDAQ: XLRN) (“ACCELERON,” “XLRN” OR THE “COMPANY”), MAKING AVORO ONE OF THE COMPANY'S MOST SIGNIFICANT SHAREHOLDERS. AVORO TODAY ISSUED THE FOLLOWING STATEMENT REITERATING WHY IT BELIEVES THAT SHAREHOLDERS SH
|
AVORO CAPITAL URGES ACCELERON SHAREHOLDERS NOT TO TENDER INTO MERCK'S INADEQUATE OFFER
|
XLRN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-09 17:31:00
| null |
NEW YORK--(BUSINESS WIRE)--AVORO CAPITAL ADVISORS (“AVORO”), A LONG-TERM AND COLLABORATIVE INVESTOR IN LIFE SCIENCES AND BIOTECHNOLOGY COMPANIES, TOGETHER WITH CERTAIN OF ITS AFFILIATES AND MANAGED FUNDS (“AVORO,” “WE” OR "US") BENEFICIALLY OWNS APPROXIMATELY 7% OF ACCELERON PHARMA INC. (NASDAQ: XLRN) (“ACCELERON”, “XLRN” OR THE “COMPANY”), MAKING AVORO ONE OF THE COMPANY'S MOST SIGNIFICANT SHAREHOLDERS. AVORO TODAY RELEASED A DETAILED PRESENTATION OUTLINING WHY SHAREHOLDERS SHOULD NOT TENDER T
|
AVORO CAPITAL RELEASES PRESENTATION DETAILING WHY ACCELERON SHAREHOLDERS SHOULD NOT TENDER INTO MERCK'S INADEQUATE OFFER
|
XLRN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-01 21:25:00
| null |
NEW YORK, NOV. 1, 2021 /PRNEWSWIRE/ -- IF YOU OWN SHARES IN ANY OF THE COMPANIES LISTED ABOVE AND WOULD LIKE TO DISCUSS OUR INVESTIGATIONS OR HAVE ANY QUESTIONS CONCERNING THIS NOTICE OR YOUR RIGHTS OR INTERESTS, PLEASE CONTACT: JOSHUA RUBIN, ESQ. WEISSLAW LLP305 BROADWAY, 7TH FLOOR NEW YORK, NY 10007 (212) 682-3025 (888) 593-4771 STOCKINFO@WEISSLAWLLP.COM DAWSON GEOPHYSICAL COMPANY (NASDAQ: DWSN) WEISSLAW LLP IS INVESTIGATING POSSIBLE BREACHES OF FIDUCIARY DUTY AND OTHER VIOLATIONS OF LAW BY THE BOARD OF DIRECTORS OF DAWSON GEOPHYSICAL COMPANY (NASDAQ: DWSN) IN CONNECTION WITH THE PROPOSED ACQUISITION OF DWSN BY A SUBSIDIARY OF WILKS BROTHERS, LLC.
|
SHAREHOLDER ALERT: WEISSLAW LLP REMINDS DWSN, PAE, XLRN, AND FLXN SHAREHOLDERS ABOUT ITS ONGOING INVESTIGATIONS
|
XLRN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-28 08:00:00
| null |
NEW YORK--(BUSINESS WIRE)--AVORO CAPITAL ADVISORS (“AVORO”), A LONG-TERM AND COLLABORATIVE INVESTOR IN LIFE SCIENCES AND BIOTECHNOLOGY COMPANIES, BENEFICIALLY OWNS APPROXIMATELY 7% OF ACCELERON PHARMA INC. (NASDAQ:XLRN) (“ACCELERON”, “XLRN” OR THE “COMPANY”) TOGETHER WITH CERTAIN OF ITS AFFILIATES AND MANAGED FUNDS (“AVORO,” “WE” OR "US"), MAKING IT ONE OF THE COMPANY'S MOST SIGNIFICANT SHAREHOLDERS. AVORO TODAY ISSUED AN OPEN LETTER TO FELLOW ACCELERON SHAREHOLDERS FURTHER DETAILING WHY THE PR
|
AVORO CAPITAL ISSUES OPEN LETTER TO FELLOW ACCELERON PHARMA SHAREHOLDERS
|
XLRN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-27 07:10:00
| null |
CAMBRIDGE, MASS.--(BUSINESS WIRE)--ACCELERON PHARMA INC. (NASDAQ:XLRN), A BIOPHARMACEUTICAL COMPANY DEDICATED TO THE DISCOVERY, DEVELOPMENT, AND COMMERCIALIZATION OF TGF-BETA SUPERFAMILY THERAPEUTICS TO TREAT SERIOUS AND RARE DISEASES, TODAY ANNOUNCED NET SALES OF REBLOZYL® (LUSPATERCEPT-AAMT) AS REPORTED BY ITS GLOBAL COLLABORATOR, BRISTOL MYERS SQUIBB, WERE APPROXIMATELY $160 MILLION FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2021. NET SALES OF REBLOZYL FOR THE THIRD QUARTER INCLUDE APPROXIMAT
|
ACCELERON ANNOUNCES THIRD QUARTER 2021 REBLOZYL® NET SALES
|
XLRN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-22 18:30:00
| null |
NEW YORK, OCT. 22, 2021 /PRNEWSWIRE/ -- IF YOU OWN SHARES IN ANY OF THE COMPANIES LISTED ABOVE AND WOULD LIKE TO DISCUSS OUR INVESTIGATIONS OR HAVE ANY QUESTIONS CONCERNING THIS NOTICE OR YOUR RIGHTS OR INTERESTS, PLEASE CONTACT: JOSHUA RUBIN, ESQ. WEISSLAW LLP305 BROADWAY, 7TH FLOOR NEW YORK, NY 10007 (212) 682-3025 (888) 593-4771 STOCKINFO@WEISSLAWLLP.COM MEREDITH CORPORATION (NYSE: MDP) WEISSLAW LLP IS INVESTIGATING POSSIBLE BREACHES OF FIDUCIARY DUTY AND OTHER VIOLATIONS OF LAW BY THE BOARD OF DIRECTORS OF MEREDITH CORPORATION (NYSE: MDP) IN CONNECTION WITH THE PROPOSED ACQUISITION OF THE COMPANY BY IAC/INTERACTIVECORP. UNDER THE TERMS OF THE MERGER AGREEMENT, MDP SHAREHOLDERS WILL RECEIVE $42.18 PER SHARE IN CASH FOR EACH SHARE OF MDP COMMON STOCK THAT THEY HOLD.
|
SHAREHOLDER ALERT: WEISSLAW LLP REMINDS MDP, GWB, XLRN AND HFC SHAREHOLDERS ABOUT ITS ONGOING INVESTIGATIONS
|
XLRN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-18 11:54:00
| null |
NEW YORK--(BUSINESS WIRE)-- #ACCELERON--BRAGAR EAGEL & SQUIRE, P.C., A NATIONALLY RECOGNIZED STOCKHOLDER RIGHTS LAW FIRM, HAS LAUNCHED AN INVESTIGATION INTO WHETHER THE OFFICERS OR DIRECTORS OF ACCELERON PHARMA INC. (NASDAQ: XLRN) BREACHED THEIR FIDUCIARY DUTIES OR VIOLATED THE FEDERAL SECURITIES LAWS IN CONNECTION WITH THE COMPANY'S ACQUISITION BY MERCK & CO., INC. (NYSE: MRK). CLICK HERE TO LEARN MORE AND PARTICIPATE IN THE ACTION. ON SEPTEMBER 30, 2021, ACCELERON ANNOUNCED THAT IT HAD ENTERED INT
|
ACCELERON PHARMA ALERT: INVESTORS SHOULD CONTACT BRAGAR EAGEL & SQUIRE, P.C. OVER TENDER OFFER FOR XLRN SHARES
|
XLRN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-13 17:56:00
| null |
NEW YORK, OCT. 13, 2021 /PRNEWSWIRE/ -- JUAN MONTEVERDE , FOUNDER AND MANAGING PARTNER AT MONTEVERDE & ASSOCIATES PC, A NATIONAL SECURITIES FIRM RATED TOP 50 IN THE 2018-2020 ISS SECURITIES CLASS ACTION SERVICES REPORT AND HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY, IS INVESTIGATING ACCELERON PHARMA INC. ( XLRN ) RELATING TO ITS PROPOSED ACQUISITION BY MERCK & CO., INC. UNDER THE TERMS OF THE AGREEMENT, XLRN SHAREHOLDERS ARE EXPECTED TO RECEIVE $180.00 IN CASH PER SHARE THEY OWN. THE INVESTIGATION FOCUSES ON WHETHER ACCELERON PHARMA INC. AND ITS BOARD OF DIRECTORS VIOLATED SECURITIES LAWS AND/OR BREACHED THEIR FIDUCIARY DUTIES TO THE COMPANY BY 1) FAILING TO CONDUCT A FAIR PROCESS, AND 2) WHETHER THE TRANSACTION IS PROPERLY VALUED.
|
SHAREHOLDER ALERT: MONTEVERDE & ASSOCIATES PC ANNOUNCES AN INVESTIGATION OF ACCELERON PHARMA INC. - XLRN
|
XLRN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-13 15:30:00
| null |
NEW YORK--(BUSINESS WIRE)--HOLOCENE ADVISORS, LP (“HOLOCENE”), A FUNDAMENTAL INVESTMENT MANAGEMENT FIRM AND SIGNIFICANT SHAREHOLDER OF ACCELERON PHARMA INC. (NASDAQ: XLRN) (“ACCELERON” OR THE “COMPANY”), TODAY ANNOUNCED THAT IT DOES NOT INTEND TO TENDER ITS SHARES INTO MERCK & CO.'S (NYSE: MRK) PROPOSED $180 PER SHARE OFFER FOR THE COMPANY ANNOUNCED ON SEPTEMBER 30, 2021. HOLOCENE STATED THE FOLLOWING: “AS A LARGE SHAREHOLDER IN ACCELERON, WE BELIEVE THE COMPANY'S MANAGEMENT TEAM HAS DONE A
|
HOLOCENE ADVISORS BELIEVES MERCK'S PROPOSED OFFER OF $180 PER SHARE FOR ACCELERON SIGNIFICANTLY UNDERVALUES COMPANY
|
XLRN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-04 16:02:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - OCTOBER 4, 2021) - THE FOLLOWING STATEMENT IS BEING ISSUED BY LEVI & KORSINSKY, LLP:TO: ALL PERSONS OR ENTITIES WHO PURCHASED ACCELERON PHARMA INC. (NASDAQ: XLRN) ("ACCELERON" OR "COMPANY") STOCK PRIOR TO SEPTEMBER 30, 2021.YOU ARE HEREBY NOTIFIED THAT LEVI & KORSINSKY, LLP HAS COMMENCED AN INVESTIGATION INTO THE FAIRNESS OF THE MERGER OF ACCELERON WITH MERCK & CO., INC. UNDER THE TERMS OF THE
|
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP NOTIFIES INVESTORS OF AN INVESTIGATION INTO THE FAIRNESS OF THE MERGER OF ACCELERON PHARMA INC. WITH MERCK & CO., INC.
|
XLRN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-01 18:27:00
| null |
NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND THE LAW FIRM OF KAHN SWICK & FOTI, LLC (“KSF”) ARE INVESTIGATING THE PROPOSED SALE OF ACCELERON PHARMA INC. (NASDAQGM: XLRN) TO MERCK (NYSE: MRK). UNDER THE TERMS OF THE PROPOSED TRANSACTION, SHAREHOLDERS OF ACCELERON WILL RECEIVE ONLY $180 IN CASH FOR EACH SHARE OF ACCELERON THAT THEY OWN. KSF IS SEEKING TO DETERMINE WHETHER THIS CONSIDERATION AND THE PROCESS THAT LED TO IT ARE ADEQUATE, OR WH
|
ACCELERON INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF ACCELERON PHARMA INC. - XLRN
|
XLRN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-30 15:52:00
| null |
NEW YORK--(BUSINESS WIRE)--AVORO CAPITAL, A LONG-TERM AND COLLABORATIVE INVESTOR IN LIFE SCIENCES AND BIOTECHNOLOGY COMPANIES, BENEFICIALLY OWNS APPROXIMATELY 7% OF ACCELERON PHARMA INC. (NASDAQ: XLRN) (“ACCELERON”, “XLRN” OR THE “COMPANY”) TOGETHER WITH CERTAIN OF ITS AFFILIATES AND MANAGED FUNDS (“AVORO,” “WE” OR "US"), MAKING IT ONE OF THE COMPANY'S MOST SIGNIFICANT SHAREHOLDERS. AVORO TODAY ISSUED THE FOLLOWING STATEMENT: DESPITE THE FACT THAT AVORO BELIEVES THAT ACCELERON'S MANAGEMENT TEAM
|
AVORO CAPITAL BELIEVES PROPOSED ACQUISITION OF ACCELERON PHARMA BY MERCK UNDERVALUES ACCELERON PHARMA
|
XLRN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-30 13:08:00
| null |
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLP, A GLOBAL INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER THE SALE OF ACCELERON PHARMA INC. (NASDAQ: XLRN) TO MERCK & CO., INC. FOR $180.00 PER SHARE IN CASH IS FAIR TO ACCELERON SHAREHOLDERS. HALPER SADEH ENCOURAGES ACCELERON SHAREHOLDERS TO CLICK HERE TO LEARN MORE ABOUT THEIR LEGAL RIGHTS AND OPTIONS OR CONTACT DANIEL SADEH OR ZACHARY HALPER AT (212) 763-0060 OR SADEH@HALPERSADEH.COM OR ZHALPER@HALPERSADEH.COM. THE INVESTIGATION CONCERNS WHE
|
ACCELERON MERGER INVESTIGATION: HALPER SADEH LLP ANNOUNCES INVESTIGATION INTO WHETHER THE SALE OF ACCELERON PHARMA INC. IS FAIR TO SHAREHOLDERS; INVESTORS ARE ENCOURAGED TO CONTACT THE FIRM – XLRN
|
XLRN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-30 10:17:00
| null |
MILWAUKEE, SEPT. 30, 2021 /PRNEWSWIRE/ -- ADEMI LLP IS INVESTIGATING ACCELERON (NASDAQ: XLRN), FOR POSSIBLE BREACHES OF FIDUCIARY DUTY AND OTHER VIOLATIONS OF LAW IN ITS TRANSACTION WITH MERCK.
|
SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER ACCELERON PHARMA INC. HAS OBTAINED A FAIR PRICE IN ITS TRANSACTION WITH MERCK
|
XLRN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-07-28 07:10:00
| null |
CAMBRIDGE, MASS.--(BUSINESS WIRE)--ACCELERON PHARMA INC. (NASDAQ:XLRN), A BIOPHARMACEUTICAL COMPANY DEDICATED TO THE DISCOVERY, DEVELOPMENT, AND COMMERCIALIZATION OF TGF-BETA SUPERFAMILY THERAPEUTICS TO TREAT SERIOUS AND RARE DISEASES, TODAY ANNOUNCED NET SALES OF REBLOZYL® (LUSPATERCEPT-AAMT) AS REPORTED BY ITS GLOBAL COLLABORATOR, BRISTOL MYERS SQUIBB, WERE APPROXIMATELY $128 MILLION FOR THE SECOND QUARTER ENDED JUNE 30, 2021. ACCELERON EXPECTS TO REPORT ROYALTY REVENUE OF APPROXIMATELY $25.6
|
ACCELERON ANNOUNCES SECOND QUARTER 2021 REBLOZYL® NET SALES
|
XLRN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-19 08:00:00
| null |
CAMBRIDGE, MASS.--(BUSINESS WIRE)--ACCELERON PHARMA INC. (NASDAQ: XLRN), A LEADING BIOPHARMACEUTICAL COMPANY IN THE DISCOVERY, DEVELOPMENT, AND COMMERCIALIZATION OF TGF-BETA SUPERFAMILY THERAPEUTICS TO TREAT SERIOUS AND RARE DISEASES, TODAY PRESENTED AT THE AMERICAN THORACIC SOCIETY 2021 INTERNATIONAL CONFERENCE (ATS 2021) PRELIMINARY INTERIM DATA FROM THE SPECTRA PHASE 2 TRIAL OF SOTATERCEPT IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH). THE FINDINGS, PRESENTED DURING THE SESSION “CLI
|
ACCELERON PRESENTS PRELIMINARY DATA FROM THE SPECTRA PHASE 2 TRIAL OF SOTATERCEPT IN PULMONARY ARTERIAL HYPERTENSION (PAH) AT THE AMERICAN THORACIC SOCIETY 2021 INTERNATIONAL CONFERENCE
|
XLRN
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.